Merck’s immunotherapy Keytruda, including a newer injectable form of the drug, showed stronger-than-expected sales.
The post Merck tops quarterly estimates, hikes profit outlook as new Keytruda form shows strength appeared first on Business News.
Merck’s immunotherapy Keytruda, including a newer injectable form of the drug, showed stronger-than-expected sales.
The post Merck tops quarterly estimates, hikes profit outlook as new Keytruda form shows strength appeared first on Business News.